Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 61 - 80 results of 14,810 for search '(( 50 we decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (nn decrease)) ))', query time: 0.52s Refine Results
  1. 61
    Summary of five key points guiding the Safe Steps evaluation and implementation.

    Summary of five key points guiding the Safe Steps evaluation and implementation. by Esario IV Daguman (21474116)

    Published 2025
    Save to List
    Saved in:
  2. 62
    Introduction of the D409V point mutation to the <i>GBA1</i> gene does not affect <i>GBA1</i> mRNA transcription or GCase protein translation.

    Introduction of the D409V point mutation to the <i>GBA1</i> gene does not affect <i>GBA1</i> mRNA transcription or GCase protein translation. by Nicole K. Polinski (10947787)

    Published 2021
    Save to List
    Saved in:
  3. 63
    Validation accuracy of our custom CNN model with the directional filters over 5 folds.

    Validation accuracy of our custom CNN model with the directional filters over 5 folds. by Salih Furkan Atici (12988243)

    Published 2022
    Save to List
    Saved in:
  4. 64
    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the Treatment of Ulcerative Colitis

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC<sub>(tofacitinib, 0–∞)</sub> and a 9.61-fold increase of colonic AUC<sub>(tofacitinib, 0–12h)</sub>, compared with tofacitinib at a molar equivalent oral dose. …”
    Save to List
    Saved in:
  5. 65
    28 days of testosterone depletion decreases fiber CSA only in the TA muscle and only at 1.5-month-old mice.

    28 days of testosterone depletion decreases fiber CSA only in the TA muscle and only at 1.5-month-old mice. by Arik Davidyan (10450896)

    Published 2021
    Save to List
    Saved in:
  6. 66
    Fig 5 -

    Fig 5 - by Lingru Ruan (18995544)

    Published 2024
    Save to List
    Saved in:
  7. 67
    Average giving in the 5€, 100€, and 1000€ treatments.

    Average giving in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

    Published 2021
    Save to List
    Saved in:
  8. 68
    Relative fold change (relative to untreated control cells) of the <i>HER-2</i> gene among LS174T and IEC-18 cells.

    Relative fold change (relative to untreated control cells) of the <i>HER-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  9. 69
    Relative fold change (relative to untreated control cells) of the <i>PTGS-2</i> gene among LS174T and IEC-18 cells.

    Relative fold change (relative to untreated control cells) of the <i>PTGS-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  10. 70
    Inactivation of one allele of FT5.

    Inactivation of one allele of FT5. by Sophia Bigot (16469992)

    Published 2023
    Save to List
    Saved in:
  11. 71
    Role of Ser77 in ACER3 catalytic site.

    Role of Ser77 in ACER3 catalytic site. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  12. 72
    Linearity of ACER3 activity assay.

    Linearity of ACER3 activity assay. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  13. 73
    The kinetics of ACER3 and mutants.

    The kinetics of ACER3 and mutants. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  14. 74
    Inhibitor assay of ACER3.

    Inhibitor assay of ACER3. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  15. 75
    Comparison between TLC and HPLC used in this study.

    Comparison between TLC and HPLC used in this study. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  16. 76
    Suggested ACER3 catalytic mechanism.

    Suggested ACER3 catalytic mechanism. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  17. 77
    HPLC chromatogram of ACER3 reaction.

    HPLC chromatogram of ACER3 reaction. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  18. 78
    The effects of neutral and alkaline ceramidase inhibitors on ACER3 activity.

    The effects of neutral and alkaline ceramidase inhibitors on ACER3 activity. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  19. 79
    HPLC chromatogram of standard NBD-C<sub>12</sub>-FA.

    HPLC chromatogram of standard NBD-C<sub>12</sub>-FA. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:
  20. 80
    Structure of ADPR2 and ACER3.

    Structure of ADPR2 and ACER3. by Jae Kyo Yi (13570063)

    Published 2022
    Save to List
    Saved in:

Search Tools: